Status and phase
Conditions
Treatments
About
This trial is a single-arm, open, multi-center phase Ib/II clinical study, which aims to evaluate the safety, tolerability, PK characteristics, immunogenicity, and Effectiveness.
Full description
This trial is divided into the combined dose escalation (Phase Ib) and the expansion phase (Phase II), as follows:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
200 participants in 1 patient group
Loading...
Central trial contact
xiaona peng
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal